We have secured funding from the Norwegian Cancer Society for a 100% postdoc position for two years. We are open for 50% appointment for four years. The project is in collaboration with the Department for Cancer Genetics, Institute for Cancer Research, which are in the forefront on molecular and genomics studies in cancer.
Treatment options for patients with recurrent gynecological cancer are limited. Immunotherapy with immune checkpoint inhibitors is a treatment modality for several types of cancer because it helps the immune system fight cancer cells. This method has recently been introduced for selected patient groups with gynecological cancer. Prospective sample collection and biobanking represent a fantastic opportunity for translational research to improve prediction of treatment response and to understand underlying resistance mechanisms. These may be tumor agnostic and generalizable across different cancer types.
NEON is a national prospective real-world study of patients with gynecological cancer with extensive biobanking, where the main goal is to collect clinical data from patients with gynecological cancer treated with immunotherapy and other new treatment methods. In addition, the goal is to raise the level of knowledge about predictive biomarkers and underlying resistance mechanisms. The project is anchored at the Gynecological Oncology Research and Clinical Trials Section at the Radiumhospitalet in Oslo. For more information, visit OUH - Section for Research and Clinical Studies. The project is conducted in collaboration with the clinical Section of gynaecological cancer as well as with the Department of Cancer Genetics, represented by Prof. Therese Sørlie. For more information about the Department, visit OUH - Dept. of Cancer Genetics.
The purpose of the Gynecological Oncology Research and Clinical Trials Section is to conduct clinical trials on gynecological cancer and promote clinical research on gynecological cancer. Currently, our unit is the 2nd largest recruiter to clinical studies in gynae-oncology in the Nordic countries. The section operates in all aspects of clinical trials, from feasibility to archiving and delivery of all relevant infrastructure to be able to treat patients in clinical trials. We are also responsible for quality assurance of clinical treatment data and reporting to national registries. The section includes the National Quality and Competence Network for Gynecological Cancer. The tasks of the network are to develop and raise the quality of patient care, education of patients, relatives and healthcare personnel at the national level. The tasks also include research and professional development, including the establishment of national and international research networks, education, dissemination of knowledge and dissemination of expertise.
Oslo University Hospital is a workplace with great diversity. We believe this is crucial to solving our tasks in the best possible way. We want this diversity to be reflected among the applicants for our positions, and encourage all qualified candidates, regardless of background, to apply!
Qualifications
Certificates, service certificates and any confirmation of a doctoral degree must be uploaded to Webcruiter, together with the application and CV, as this forms the basis for calculating educational seniority and determining salary.
In order for you to thrive with us, there are some personal qualities that are key :
We offer
Oslo University Hospital has an important social mission in offering good and equal healthcare services to the population. As a doctor at our hospital, you will have a central role in fulfilling this. You are of great importance for patient safety, well-being in the workplace and the development of a safe, open and inclusive culture.
We are committed to your well-being and development, read below what we can offer you :
At Oslo University Hospital, we engage in advanced patient care, research, experimental treatment, teaching and innovation at a high international level. We are therefore the rearguard of all of Norway! We need you on the team!
Oslo University Hospital is a highly specialized hospital in charge of extensive regional and local hospital assignments. As Scandinavia’s largest hospital, we carry out more than 1.2 million patient treatments each year. The hospital has a nationwide responsibility for a number of national and multi-regional assignments, and has several national centers of competence. Oslo University Hospital is responsible for approximately 50 percent of all medical and health care research conducted at Norwegian hospitals, and is a significant role player within the education of a large variety of health care personnel.
#J-18808-Ljbffr
Postdoc • Oslo, Oslo fylke, Norge